Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes

scientific article published on September 2006

Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-06-1864
P698PubMed publication ID16982755

P50authorTakashi KojimaQ91715542
P2093author name stringMasaki Murata
Norimasa Sawada
Hideki Chiba
Makoto Osanai
Nami Nishikiori
P433issue18
P407language of work or nameEnglishQ1860
P921main subjectgene silencingQ1431332
P304page(s)9125-9133
P577publication date2006-09-01
P1433published inCancer ResearchQ326097
P1476titleEpigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes
P478volume66

Reverse relations

cites work (P2860)
Q40156970A novel monoclonal antibody against the second extracellular loop of occludin disrupts epithelial cell polarity
Q39980778A novel splice variant of occludin deleted in exon 9 and its role in cell apoptosis and invasion
Q34162439Adaptive Calcified Matrix Response of Dental Pulp to Bacterial Invasion Is Associated with Establishment of a Network of Glial Fibrillary Acidic Protein+/Glutamine Synthetase+ Cells
Q60907845Anti-breast Cancer Activity of SPG-56 from Sweet Potato in MCF-7 Bearing Mice in Situ through Promoting Apoptosis and Inhibiting Metastasis
Q35369905BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma
Q37113161Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells
Q39631925Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.
Q36773956Claudin-7 increases chemosensitivity to cisplatin through the upregulation of caspase pathway in human NCI-H522 lung cancer cells
Q51625972Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.
Q37400120Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma
Q39676905Co-culture based blood-brain barrier in vitro model, a tissue engineering approach using immortalized cell lines for drug transport study
Q50505471Connexins, E-cadherin, Claudin-7 and β-catenin transiently form junctional nexuses during the post-natal mammary gland development.
Q92744259Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes
Q33517866Disruption of occludin function in polarized epithelial cells activates the extrinsic pathway of apoptosis leading to cell extrusion without loss of transepithelial resistance
Q38245421Dissecting the role of polarity regulators in cancer through the use of mouse models.
Q47161653Dual Functioned Pegylated Phospholipid Micelles Containing Cationic Antimicrobial Decapeptide for Treating Sepsis
Q64963332Effect of calprotectin subunit S100A9 on the expression and methylation of OCLN in human melanoma cell line A-375.
Q52580604Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells.
Q37730957Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis
Q37866083Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment
Q39102508Gut permeability and mucosal inflammation: bad, good or context dependent.
Q42108832Hippo pathway elements Co-localize with Occludin: A possible sensor system in pancreatic epithelial cells
Q26768428Homeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer Progression
Q27653352Identification and Analysis of Occludin Phosphosites: A Combined Mass Spectrometry and Bioinformatics Approach
Q54951433Macrophages induce "budding" in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions.
Q28482133Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma
Q42418341Occludin S471 Phosphorylation Contributes to Epithelial Monolayer Maturation.
Q36217272Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)
Q34580003Occludin is involved in adhesion, apoptosis, differentiation and Ca2+-homeostasis of human keratinocytes: implications for tumorigenesis
Q35182998Occludin localizes to centrosomes and modifies mitotic entry
Q40141217Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells
Q37956234Occludin: one protein, many forms
Q43236391Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1.
Q26787279Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis
Q46709248RNA sequencing supports distinct reactive oxygen species-mediated pathways of apoptosis by high and low size mass fractions of Bay leaf (Lauris nobilis) in HT-29 cells
Q39906454Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin
Q38594976Role of tight junctions in signal transduction: an update.
Q103805908TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms
Q26740056Tight Junctions and the Tumor Microenvironment
Q36343793Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases
Q37118065Tight junction proteins: from barrier to tumorigenesis.
Q38077200Tight junction-related human diseases
Q37420725Tight junctions: a barrier to the initiation and progression of breast cancer?
Q92127865Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression

Search more.